We are live on ! Find out more
SBL

Sargent Bickham Lagudis Portfolio holdings

AUM $1.22B
1-Year Est. Return 14.94%
This Fund
S&P 500
This Quarter Est. Return
+8.08%
1 Year Est. Return
-14.94%
3 Year Est. Return
+19.11%
5 Year Est. Return
+40.37%
10 Year Est. Return
AUM
$1.33B
AUM Growth
+$96.9M
Cap. Flow
+$308M
Cap. Flow %
23.26%
Top 10 Hldgs %
41.88%
Holding
1,051
New
66
Increased
215
Reduced
200
Closed
50

Sector Composition

Rank Sector Weight
1 Technology 7.87%
2 Healthcare 6.61%
3 Financials 5.04%
4 Consumer Discretionary 4.73%
5 Communication Services 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSX icon
176
CSX Corp
CSX
$94B
$480K 0.04%
12,774
-1,194
-9% -$42.1K
AOM icon
177
iShares Core Moderate Allocation ETF
AOM
$1.74B
$479K 0.04%
10,529
XEL icon
178
Xcel Energy
XEL
$49.2B
$477K 0.04%
7,047
-387
-5% -$25.2K
BSCO
179
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$476K 0.04%
21,824
-906
-4% -$19.9K
GLD icon
180
SPDR Gold Trust
GLD
$131B
$454K 0.03%
2,658
-273
-9% -$45.8K
HBAN icon
181
Huntington Bancshares
HBAN
$34B
$450K 0.03%
29,166
-2,616
-8% -$41.2K
IGIB icon
182
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$448K 0.03%
7,566
SPDW icon
183
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$39.3B
$446K 0.03%
12,232
+253
+2% +$9.31K
NGG icon
184
National Grid
NGG
$79.3B
$443K 0.03%
6,804
+430
+7% +$25.2K
IWD icon
185
iShares Russell 1000 Value ETF
IWD
$81.4B
$428K 0.03%
2,548
+166
+7% +$27.2K
ZBH icon
186
Zimmer Biomet
ZBH
$18.8B
$410K 0.03%
3,321
+1
+0% +$131
CRM icon
187
Salesforce
CRM
$154B
$406K 0.03%
1,597
+16
+1% +$4.5K
VHT icon
188
Vanguard Health Care ETF
VHT
$18.5B
$394K 0.03%
1,480
AMGN icon
189
Amgen
AMGN
$209B
$389K 0.03%
1,727
-23
-1% -$4.85K
NVS icon
190
Novartis
NVS
$302B
$389K 0.03%
4,447
-123
-3% -$10.2K
DEO icon
191
Diageo
DEO
$49.6B
$386K 0.03%
1,755
-49
-3% -$10K
CAKE icon
192
Cheesecake Factory
CAKE
$5.03B
$383K 0.03%
9,795
SCHW
193
Charles Schwab
SCHW
$182B
$378K 0.03%
4,494
HYS icon
194
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.74B
$347K 0.03%
3,506
+3,179
+972% +$314K
RSPH icon
195
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$773M
$338K 0.03%
10,550
USB icon
196
US Bancorp
USB
$97.9B
$338K 0.03%
6,022
+49
+0.8% +$2.9K
VV icon
197
Vanguard Morningstar Large-Cap ETF
VV
$51.2B
$335K 0.03%
1,515
BA icon
198
Boeing
BA
$169B
$322K 0.02%
1,597
IJH icon
199
iShares Core S&P Mid-Cap ETF
IJH
$121B
$320K 0.02%
5,660
NUHY icon
200
Nuveen ESG High Yield Corporate Bond ETF
NUHY
$110M
$318K 0.02%
13,042
-4,386
-25% -$107K

Similar funds

Sargent Bickham Lagudis's Q4 2021 Portfolio in Review

As of Q4 2021, Sargent Bickham Lagudis held 1,051 positions worth $1.33B, up 7.9% from $1.23B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sargent Bickham Lagudis deployed $308M of net new capital in Q4 2021, opening 66 new positions and adding to 215 existing holdings. Its largest new stake was Schwab International Dividend Equity ETF: 4,261 shares worth $109K.

By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 6.9% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $10.2M trimmed.

  • Sargent Bickham Lagudis's largest Q4 2021 buy was Schwab International Dividend Equity ETF: 4,261 shares worth $109K.
  • Sargent Bickham Lagudis added most to Berkshire Hathaway Class A in Q4 2021, an estimated $302M increase.
  • Sargent Bickham Lagudis's biggest Q4 2021 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $10.2M.
  • Sargent Bickham Lagudis fully exited Invesco BulletShares 2021 Corporate Bond ETF in Q4 2021, selling an estimated $1.33M.
  • Sargent Bickham Lagudis's ten largest holdings make up 42% of its $1.33B portfolio in Q4 2021.
  • Sargent Bickham Lagudis opened 66 new positions and closed 50 in Q4 2021.
  • Sargent Bickham Lagudis's portfolio value rose 7.9% quarter-over-quarter to $1.33B.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2021, filed 18 Jan 2022.